Pfizer China

Pfizer China entered the Chinese market in 1989. Having been rooted in China for 36 years, Pfizer China has become one of the major foreign pharmaceutical companies in China. At present, Pfizer China business in China covers more than 300 cities across the country and has established one advanced production facility, three research and development centers (located in Zhangjiang High tech Park in Shanghai, Optics Valley in Wuhan, and Bio Park International Medical Innovation Park in Beijing Economic and Technological Development Zone), and one Huirui Zhihui Medical Innovation Center (Hangzhou). Since entering China, Pfizer China has launched over 80 innovative drugs and vaccines, with a strong and comprehensive product line aimed at meeting the health needs of all stages of life. At present, Pfizer China focuses on six major areas in the Chinese market: oncology, anti infection, inflammation and immunity, rare diseases, migraine, and vaccines. With patient needs at the center, Pfizer China provides high-quality innovative products and treatment plans for Chinese patients.